2633 — Jacobson Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.29bn
- HK$1.65bn
- HK$1.47bn
- 81
- 95
- 67
- 97
Annual cashflow statement for Jacobson Pharma, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 263 | 221 | 231 | 340 | — |
| Depreciation | |||||
| Non-Cash Items | 50.8 | 24.6 | 17.3 | 66.6 | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -119 | -27.6 | -34.4 | 39.2 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 361 | 409 | 407 | 630 | — |
| Capital Expenditures | -84.4 | -63.4 | -63.9 | -63 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -353 | -310 | 13.9 | -72 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -438 | -373 | -49.9 | -135 | — |
| Financing Cash Flow Items | -49.1 | 14.3 | -26.6 | -72.4 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -133 | 21.4 | -358 | -36.6 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -208 | 58.9 | -1.7 | 458 | — |